Israel’s ProteKt Therapeutics is developing a treatment for early stage Alzheimer’s disease. It inhibits the PKR enzyme that is over-expressed in Alzheimer’s patients and may slow or even reverse the progress of the disease. It also has potential for ALS, Huntington and Parkinson’s.
https://www.timesofisrael.com/israeli-startup-hopes-to-battle-alzheimers-with-enzyme-busting-drug/